<p>Patients with IgAN (IgAN) showed higher urinary levels of CXCL1 (A) and TGF-β1 (B) than that in healthy controls (HC) (CXCL1: 43.85±142.49 pg/mg Vs 1.38±4.09 pg/mg, p<0.01; TGF-β1: 107.56±283.95 pg/mg Vs 43.83±33.85 pg/mg, p=0.026). Individual symbols represent individual person (104 IgAN patients and 74 healthy controls).</p
Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (Ig...
<p>Plasma suPAR levels of patients with IgA nephopathy (IgAN, 2298, IQR 1776–2956 pg/mL) were signif...
<p>The number of patients with nephrotic syndrome among IgAN and primary FSGS were 34 and 73, respec...
<p>Urinary CXCL1 was calibrated against urine creatinine before the levels were compared. The urinar...
<p>Compared with from healthy controls (HC), cIgA1 from IgAN patients (IgAN) significantly up-regula...
<p>Patients with IgAN were divided into two groups, according to the median urinary CXCL1 level (18....
<p>We divided IgAN patients into two subgroups: patients with serum levels of Gd-IgA1 ≥ the 90<sup>t...
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide. In recent ye...
<p>Plasma sFlt-1, VEGF, VEGF/sFlt-1 levels of enrolled IgAN patients and healthy volunteers in the d...
<p>Each biomarker was measured by capture ELISA. The serum levels of Gd-IgA, Gd-IgA1-specific IgG an...
Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (Ig...
<p>Values are presented as the means ± standard deviation (SD) if the variables showed a normal dist...
Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (Ig...
<p>Correlation of serum CXCL16 levels with CCR (A), eGFR (B), creatinine (C), BUN (D), 24 h proteinu...
<p>IGF-1 levels and IGF-1 SDS in patients without renal lesions were significantly different from pa...
Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (Ig...
<p>Plasma suPAR levels of patients with IgA nephopathy (IgAN, 2298, IQR 1776–2956 pg/mL) were signif...
<p>The number of patients with nephrotic syndrome among IgAN and primary FSGS were 34 and 73, respec...
<p>Urinary CXCL1 was calibrated against urine creatinine before the levels were compared. The urinar...
<p>Compared with from healthy controls (HC), cIgA1 from IgAN patients (IgAN) significantly up-regula...
<p>Patients with IgAN were divided into two groups, according to the median urinary CXCL1 level (18....
<p>We divided IgAN patients into two subgroups: patients with serum levels of Gd-IgA1 ≥ the 90<sup>t...
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide. In recent ye...
<p>Plasma sFlt-1, VEGF, VEGF/sFlt-1 levels of enrolled IgAN patients and healthy volunteers in the d...
<p>Each biomarker was measured by capture ELISA. The serum levels of Gd-IgA, Gd-IgA1-specific IgG an...
Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (Ig...
<p>Values are presented as the means ± standard deviation (SD) if the variables showed a normal dist...
Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (Ig...
<p>Correlation of serum CXCL16 levels with CCR (A), eGFR (B), creatinine (C), BUN (D), 24 h proteinu...
<p>IGF-1 levels and IGF-1 SDS in patients without renal lesions were significantly different from pa...
Podocyte loss has been reported to relate to disease severity and progression in IgA nephropathy (Ig...
<p>Plasma suPAR levels of patients with IgA nephopathy (IgAN, 2298, IQR 1776–2956 pg/mL) were signif...
<p>The number of patients with nephrotic syndrome among IgAN and primary FSGS were 34 and 73, respec...